Kenya vs Togo: HIV positive pregnant women receiving antiretrovirals, using
HIV positive pregnant women receiving antiretrovirals, using over time
- Kenya
- Togo
How they compare
Togo currently reports 79.0% against 75.0% in Kenya, a difference of 4.0%.
That makes Togo's figure about 1.1 times Kenya's.
The two have swapped places 1 time across 6 shared years of data; in 2004 it was Kenya ahead.
Kenya ranks 13th and Togo ranks 11th of 38 countries.
Across the 2 decades both report, Kenya averaged higher in 1 and Togo in 1.
Head to head by decade
| Decade | Kenya | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 57.6% | 21.2% | 36.4% | Kenya |
| 2010s | 75.0% | 79.0% | 4.0% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv positive pregnant women receiving antiretrovirals, using, Kenya or Togo?
- Togo, at 79.0% against 75.0% in Kenya as of 2011.
- What is the difference in hiv positive pregnant women receiving antiretrovirals, using between Kenya and Togo?
- 4.0%, with Togo ahead.
- How many years of comparable data are there for Kenya and Togo?
- 6 years are reported by both, from 2004 to 2011.
- How do Kenya and Togo rank globally for hiv positive pregnant women receiving antiretrovirals, using?
- Kenya ranks 13th and Togo ranks 11th of 38 countries.
- Where does this data come from?
- http://data.unaids.org/pub/GlobalReport/2008/, published as HIV positive pregnant women receiving antiretrovirals, using WHO/UNAIDS methodology (%; high estimate). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of HIV-infected pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission. Numerator: Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. Denominator: Estimated number of HIV-infected pregnant women in the last 12 months. Ranges are presented for countries with low and concentrated epidemics. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV. All data reflect values representing 12 month period ending December 2007 which have been reconciled between reporting country and UNAIDS/WHO/UNICEF, unless otherwise noted. All analysis of this indicator, including quoted country figures, reflect numerators which have gone through a tri agency reconciliation (UNAIDS/WHO/UNICEF) process and denominators which have been estimated directly from the UNAIDS/WHO Reference group on Estimates, Modelling and Projections methodology (Spectrum). The reconciliation process ensured all agencies reported the same country endorsed figure which was the most recent and met the definition of HIV-infected women receiving antiretroviral drugs over the last 12 months, and thus reflect a full year. Every effort was made in cases of discrepancy across the three agencies to obtain approval from the country on a final indicator value.